Tonkin A
Aust N Z J Med. 1981 Dec;11(6):697-705. doi: 10.1111/j.1445-5994.1981.tb03549.x.
While the principles of drug management of supraventricular tachyarrhythmias have remained essentially unchanged, such treatment remains empirical in many patients. Recent advances in the understanding of electrophysiological mechanisms have not only rationalised treatment but dictated newer approaches to these and other arrhythmias.